AI Use Case: Ari�� The First and Only Brand Design Application Engineered for Pharma Naming

Session details:

Pharmaceutical naming today faces a perfect storm: shrinking regulatory and trademark whitespace coupled with the ever-present aspiration to create a name that forms the foundation of a great brand. Necessary safety and trademark constraints can strip away your brand’s strategy, leaving the final product void of a story that drives long-term market success.

Enter Ari™, Addison Whitney’s proprietary AI brand design application customized for pharma naming. Ari™ unleashes creative generation, by conducting real-time compliance screening and shifting the focus squarely on strategic alignment in a single, secure environment—transforming how brand teams create, evaluate, and advance names.

Launched in early 2025, there are several learnings, updates, and use-cases to share. Join Joe Daley, President of Addison Whtiney, and Dorothy Linvill-Neal, Director of Brand Development and Strategy at Regeneron, to see how Ari™ is delivering trademarks without tradeoffs.